Cargando…
Buprenorphine/naloxone induction for treatment of acute on chronic pain using a micro-dosing regimen: A case report
Background: Due to its unique pharmacologic properties, efficacy as an analgesic, and role as a first-line medication for the treatment of opioid use disorder, sublingual buprenorphine has emerged as a treatment for patients with concurrent chronic pain and opioid use disorders. One challenge to uti...
Autores principales: | Sandhu, Raman, Zivanovic, Rebecca, Klaire, Sukhpreet, Nikoo, Mohammadali, Rozylo, Jennifer, Azar, Pouya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730552/ https://www.ncbi.nlm.nih.gov/pubmed/35005396 http://dx.doi.org/10.1080/24740527.2019.1599279 |
Ejemplares similares
-
Case report: Successful induction of buprenorphine/naloxone using a microdosing schedule and assertive outreach
por: Rozylo, Jennifer, et al.
Publicado: (2020) -
Comparing rapid micro-induction and standard induction of buprenorphine/naloxone for treatment of opioid use disorder: protocol for an open-label, parallel-group, superiority, randomized controlled trial
por: Wong, James S. H., et al.
Publicado: (2021) -
Successful Buprenorphine/Naloxone Low-dose Induction in Pregnancy: A Case Report
por: Coish, Rebecca, et al.
Publicado: (2023) -
Low-dose naloxone provides an abuse-deterrent effect to buprenorphine
por: Webster, Lynn R, et al.
Publicado: (2015) -
Microdose induction of buprenorphine-naloxone in a patient using high dose methadone: A case report
por: Menard, Shannon, et al.
Publicado: (2021)